News
4h
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Tirzepatide reduces breast tumor growth in obese mice while improving metabolic health, offering hope as a dual-action cancer ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction.
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Oral PL7737 monotherapy produced rapid and significant weight loss after just 4 days of treatment <li /> Combination of oral PL7737 ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study. People with type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results